Channing Laboratory, Brigham and Women's Hospital, Boston, MA 02115, USA.
Immunol Rev. 2012 Jan;245(1):13-26. doi: 10.1111/j.1600-065X.2011.01075.x.
Over the past several years, there have been remarkable advances in our understanding of how commensal organisms shape host immunity. Although the full cast of immunogenic bacteria and their immunomodulatory molecules remains to be elucidated, lessons learned from the interactions between bacterial zwitterionic polysaccharides (ZPSs) and the host immune system represent an integral step toward better understanding how the intestinal microbiota effect immunologic changes. Somewhat paradoxically, ZPSs, which are found in numerous commensal organisms, are able to elicit both proinflammatory and immunoregulatory responses; both these outcomes involve fine-tuning the balance between T-helper 17 cells and interleukin-10-producing regulatory T cells. In this review, we discuss the immunomodulatory effects of the archetypal ZPS, Bacteroides fragilis PSA. In addition, we highlight some of the opportunities and challenges in applying these lessons in clinical settings.
在过去的几年中,人们对共生生物如何塑造宿主免疫有了显著的认识。尽管完整的免疫原性细菌及其免疫调节分子尚未阐明,但从细菌两性离子多糖(ZPS)与宿主免疫系统之间的相互作用中获得的经验教训代表了更好地理解肠道微生物群如何影响免疫变化的重要一步。有些矛盾的是,存在于许多共生生物中的 ZPS 能够引发促炎和免疫调节反应;这两种结果都涉及到调节辅助性 T 细胞 17 细胞和白细胞介素 10 产生的调节性 T 细胞之间的平衡。在这篇综述中,我们讨论了典型 ZPS ,脆弱拟杆菌 PSA 的免疫调节作用。此外,我们还强调了在临床环境中应用这些经验教训的一些机遇和挑战。